Inhibitors & Compound Libraries

Name	Typ	Specific against	Appl.	ArtNr.	Menge	Preis
GLUT inhibitor-1	Inhibitors	Other		DCC-DC60220-1g DCChemicals	1 g	Anmelden Vergleichen	GLUT inhibitor-1
DOTMA	Inhibitors	Other	N, N-[1-(2, 3-Dioleyloxy)propyl]-N, N-trimethylammonium (DOTMA) is a cationic lipid.1 It has been used as a component in liposomes that can be used to encapsulate siRNA, microRNAs, and oligonucleotides and for gene transfection in vitro.1, 2	DCC-DC60213-1g DCChemicals	1 g	Anmelden Vergleichen	DOTMA
DWN63831	Inhibitors	Other	ELISA, other	DCC-DC60092-100mg DCChemicals	100 mg	Anmelden Vergleichen	DWN63831
DWN63831	Inhibitors	Other	ELISA, other	DCC-DC60092-250mg DCChemicals	250 mg	Anmelden Vergleichen	DWN63831
DWN63831	Inhibitors	Other	ELISA, other	DCC-DC60092-1g DCChemicals	1 g	Anmelden Vergleichen	DWN63831
MUN36378	Inhibitors	Other		DCC-DC60107-100mg DCChemicals	100 mg	Anmelden Vergleichen	MUN36378
MUN36378	Inhibitors	Other		DCC-DC60107-250mg DCChemicals	250 mg	Anmelden Vergleichen	MUN36378
MUN36378	Inhibitors	Other		DCC-DC60107-1g DCChemicals	1 g	Anmelden Vergleichen	MUN36378
RS-25344 hydrochloride	Inhibitors	Other	IC	DCC-DC60117-100mg DCChemicals	100 mg	Anmelden Vergleichen	RS-25344 hydrochloride
RS-25344 hydrochloride	Inhibitors	Other	IC	DCC-DC60117-250mg DCChemicals	250 mg	Anmelden Vergleichen	RS-25344 hydrochloride
RS-25344 hydrochloride	Inhibitors	Other	IC	DCC-DC60117-1g DCChemicals	1 g	Anmelden Vergleichen	RS-25344 hydrochloride
SR 18662	Inhibitors	Other	FC, IV	DCC-DC60201-100mg DCChemicals	100 mg	Anmelden Vergleichen	SR 18662
SR 18662	Inhibitors	Other	FC, IV	DCC-DC60201-250mg DCChemicals	250 mg	Anmelden Vergleichen	SR 18662
SR 18662	Inhibitors	Other	FC, IV	DCC-DC60201-1g DCChemicals	1 g	Anmelden Vergleichen	SR 18662
JH-X-119-01	Inhibitors	Other	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.	DCC-DC60125-100mg DCChemicals	100 mg	Anmelden Vergleichen	JH-X-119-01
JH-X-119-01	Inhibitors	Other	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.	DCC-DC60125-250mg DCChemicals	250 mg	Anmelden Vergleichen	JH-X-119-01
JH-X-119-01	Inhibitors	Other	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.	DCC-DC60125-1g DCChemicals	1 g	Anmelden Vergleichen	JH-X-119-01
M1001	Inhibitors	Other	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281	DCC-DC60176-100mg DCChemicals	100 mg	Anmelden Vergleichen	M1001
M1001	Inhibitors	Other	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281	DCC-DC60176-250mg DCChemicals	250 mg	Anmelden Vergleichen	M1001
M1001	Inhibitors	Other	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281	DCC-DC60176-1g DCChemicals	1 g	Anmelden Vergleichen	M1001
Bifluranol	Inhibitors	Other	Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro, consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels.	DCC-DC60199-100mg DCChemicals	100 mg	Anmelden Vergleichen	Bifluranol
Bifluranol	Inhibitors	Other	consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels., Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro	DCC-DC60199-250mg DCChemicals	250 mg	Anmelden Vergleichen	Bifluranol
Bifluranol	Inhibitors	Other	consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels., Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro	DCC-DC60199-1g DCChemicals	1 g	Anmelden Vergleichen	Bifluranol
Giredestrant (tartrate)	Inhibitors	Other	with potential antineoplastic activity. Upon oral administration, Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally available selective estrogen receptor degrader/downregulator (SERD), SERD GDC-9545 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation.	DCC-DC60185-100mg DCChemicals	100 mg	Anmelden Vergleichen	Giredestrant (tartrate)
Giredestrant (tartrate)	Inhibitors	Other	with potential antineoplastic activity. Upon oral administration, Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally available selective estrogen receptor degrader/downregulator (SERD), SERD GDC-9545 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation.	DCC-DC60185-250mg DCChemicals	250 mg	Anmelden Vergleichen	Giredestrant (tartrate)

Name Preis

GLUT inhibitor-1

Anmelden

GLUT inhibitor-1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC60220-1g
Menge	1 g
Lieferbar

DOTMA

Anmelden

DOTMA

Typ	Inhibitors
Clone
Specific against	Other
Appl.	N, N-[1-(2, 3-Dioleyloxy)propyl]-N, N-trimethylammonium (DOTMA) is a cationic lipid.1 It has been used as a component in liposomes that can be used to encapsulate siRNA, microRNAs, and oligonucleotides and for gene transfection in vitro.1, 2
Host
ArtNr.	DCC-DC60213-1g
Menge	1 g
Lieferbar

DWN63831

Anmelden

DWN63831

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ELISA, other
Host
ArtNr.	DCC-DC60092-100mg
Menge	100 mg
Lieferbar

DWN63831

Anmelden

DWN63831

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ELISA, other
Host
ArtNr.	DCC-DC60092-250mg
Menge	250 mg
Lieferbar

DWN63831

Anmelden

DWN63831

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ELISA, other
Host
ArtNr.	DCC-DC60092-1g
Menge	1 g
Lieferbar

MUN36378

Anmelden

MUN36378

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC60107-100mg
Menge	100 mg
Lieferbar

MUN36378

Anmelden

MUN36378

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC60107-250mg
Menge	250 mg
Lieferbar

MUN36378

Anmelden

MUN36378

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC60107-1g
Menge	1 g
Lieferbar

RS-25344 hydrochloride

Anmelden

RS-25344 hydrochloride

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC60117-100mg
Menge	100 mg
Lieferbar

RS-25344 hydrochloride

Anmelden

RS-25344 hydrochloride

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC60117-250mg
Menge	250 mg
Lieferbar

RS-25344 hydrochloride

Anmelden

RS-25344 hydrochloride

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC60117-1g
Menge	1 g
Lieferbar

SR 18662

Anmelden

SR 18662

Typ	Inhibitors
Clone
Specific against	Other
Appl.	FC, IV
Host
ArtNr.	DCC-DC60201-100mg
Menge	100 mg
Lieferbar

SR 18662

Anmelden

SR 18662

Typ	Inhibitors
Clone
Specific against	Other
Appl.	FC, IV
Host
ArtNr.	DCC-DC60201-250mg
Menge	250 mg
Lieferbar

SR 18662

Anmelden

SR 18662

Typ	Inhibitors
Clone
Specific against	Other
Appl.	FC, IV
Host
ArtNr.	DCC-DC60201-1g
Menge	1 g
Lieferbar

JH-X-119-01

Anmelden

JH-X-119-01

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.
Host
ArtNr.	DCC-DC60125-100mg
Menge	100 mg
Lieferbar

JH-X-119-01

Anmelden

JH-X-119-01

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.
Host
ArtNr.	DCC-DC60125-250mg
Menge	250 mg
Lieferbar

JH-X-119-01

Anmelden

JH-X-119-01

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Jh-X-119-01 is a novel potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 irreversibly labels IRAK1 at C302. This compound exhibited cytotoxic activity at single digit micromolar concentrations in a panel of WM, DLBCL, and lymphoma cell lines expressing MYD88. Cotreatment of JH-X-119-01 with the BTK inhibitor ibrutinib resulted in synergistic killing effects in these systems.
Host
ArtNr.	DCC-DC60125-1g
Menge	1 g
Lieferbar

M1001

Anmelden

M1001

Typ	Inhibitors
Clone
Specific against	Other
Appl.	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281
Host
ArtNr.	DCC-DC60176-100mg
Menge	100 mg
Lieferbar

M1001

Anmelden

M1001

Typ	Inhibitors
Clone
Specific against	Other
Appl.	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281
Host
ArtNr.	DCC-DC60176-250mg
Menge	250 mg
Lieferbar

M1001

Anmelden

M1001

Typ	Inhibitors
Clone
Specific against	Other
Appl.	M1001 is a novel allosteric agonist of hypoxia-inducible factor-2α subunit (hif-2α), significantly displacing pocket residue y281
Host
ArtNr.	DCC-DC60176-1g
Menge	1 g
Lieferbar

Bifluranol

Anmelden

Bifluranol

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro, consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels.
Host
ArtNr.	DCC-DC60199-100mg
Menge	100 mg
Lieferbar

Bifluranol

Anmelden

Bifluranol

Typ	Inhibitors
Clone
Specific against	Other
Appl.	consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels., Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro
Host
ArtNr.	DCC-DC60199-250mg
Menge	250 mg
Lieferbar

Bifluranol

Anmelden

Bifluranol

Typ	Inhibitors
Clone
Specific against	Other
Appl.	consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels., Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign pro
Host
ArtNr.	DCC-DC60199-1g
Menge	1 g
Lieferbar

Giredestrant (tartrate)

Anmelden

Giredestrant (tartrate)

Typ	Inhibitors
Clone
Specific against	Other
Appl.	with potential antineoplastic activity. Upon oral administration, Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally available selective estrogen receptor degrader/downregulator (SERD), SERD GDC-9545 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation.
Host
ArtNr.	DCC-DC60185-100mg
Menge	100 mg
Lieferbar

Giredestrant (tartrate)

Anmelden

Giredestrant (tartrate)

Typ	Inhibitors
Clone
Specific against	Other
Appl.	with potential antineoplastic activity. Upon oral administration, Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally available selective estrogen receptor degrader/downregulator (SERD), SERD GDC-9545 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation.
Host
ArtNr.	DCC-DC60185-250mg
Menge	250 mg
Lieferbar

Inhibitors & Compound Libraries

Kontakt

Über Hölzel

Service

Infothek

ANMELDEN & VORTEILE SICHERN

Ergebnisse filtern

Inhibitors & Compound Libraries

Kontakt

Über Hölzel

Service

Infothek